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Abstract
Fluid flow through large interstitial spaces is sensed at the cellular level, and mechanistic responses to flow changes enables
expansion or contraction of the cells modulating the surrounding area and brings about changes in fluid flow. In the
anterior eye chamber, aqueous humor, a clear fluid, flows through trabecular meshwork (TM), a filter like region. Cochlin, a
secreted protein in the extracellular matrix, was identified in the TM of glaucomatous patients but not controls by mass
spectrometry. Cochlin undergoes shear induced multimerization and plays a role in mechanosensing of fluid shear.
Cytoskeletal changes in response to mechanosensing in the ECM by cochlin will necessitate transduction of
mechanosensing. TREK-1, a stretch activated outward rectifying potassium channel protein known to act as
mechanotransducer was found to be expressed in TM. Cochlin expression results in co-expression of TREK-1 and filopodia
formation. Prolonged cochlin expression results in expression and subsequent secretion of annexin A2, a protein known to
play a role in cytoskeletal remodeling. Cochlin interacts with TREK-1 and annexin A2. Cochlin-TREK-1 interaction has
functional consequences and results in changes in cell shape and motility. Annexin A2 expression and secretion follows
cochlin-TREK-1 syn-expression and correlates with cell elongation. Thus cytoskeleton changes in response to fluid shear
sensed by cochlin are further mediated by TREK-1 and annexin A2.
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Introduction
A number of late onset and progressive diseases for example,
glaucoma and idiopathic intracranial hypertension are associated
with fluid flow abnormalities. Cells dynamically responds to fluid
shear, however, such mechanosensing and their responses are yet
to be well understood at the molecular level. Altered properties of
the cells of a filter like structure termed trabecular meshwork (TM)
in the anterior eye chamber are thought to cause fluid shear
abnormalities leading to aqueous outflow dysregulation, intraoc-
ular pressure (IOP) fluctuations and glaucoma [1,2]. Physiologi-
cally how the cells of the TM region sense and respond to different
fluid flow regimes controlling geometry and area of the filter
remains to be elucidated. Two distinct components are envisaged
for regulation of fluid flow: a mechanosensor residing at the
extracellular matrix (ECM) and transmembrane mechanotransdu-
cers residing at the cell surface.
Cochlin, a secreted protein identified in the glaucomatous, but
not normal TM, by mass spectrometry was found to undergo
multimerization in response to fluid shear [3]. Cochlin bears two
von Willebrand factor A-like (vWFA) domains that are found in
fluid shear responsive ECM proteins [4]. Fluid shear induces
cochlin multimerization suggesting cochlin to possess mechan-
osensing capability [3]. Experiments performed in DBA/2J mice,
monkey, and porcine cultured anterior segments [5,6] and
normotensive rabbits [7] are consistent with a key role for cochlin
in IOP regulation. The fluid flow changes must be sensed by cells
in order to regulate the structure of the TM that allows passage of
aqueous humor and to regulate its flow. Fluid shear responsive
property of cochlin in consonance with transmembrane shear
transducing proteins stretch activated channels (SACs) such as
TREK-1 [8,9] is likely to play a role in mechanotransduction and
tissue modeling. Stretch-activated channels have been proposed to
be ocular barometers [10]. TREK-1 is a mechanosensitive stretch
activated potassium channel [11]. TREK-1 is expressed at mRNA
level in the TM [accession number GDS 359; gene expression
omnibus (GEO) database]. The TREK-1 channel undergoes
mechano-, pH- and voltage-dependent gating and also possesses a
domain to interact with membrane phospholipids. TREK-1
activation alters the cytoskeletal network, induces actin cytoskel-
eton remodeling and is involved in formation of actin- rich
membrane protrusions [11,12]. The transduction of mechanosen-
sing by cochlin with TREK-1 is thus plausible, which may lead to
remodeling of TM cell cytoskeleton rendering increased passage
for aqueous humor. Cell motility and adhesion require a dynamic
remodelling of the membrane-associated actin cytoskeleton in
response to extracellular stimuli (such as changing fluid shear).
Rho-mediated actin rearrangement of TM cells has implicated in
regulation of aqueous outflow [13]. A tyrosine phosphorylation
switch in annexin A2 has been shown to be an important event in
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cell morphology associated with cell adhesion [14,15]. We have
previously determined interaction of cochlin with annexin A2
using mass spectrometry [16]. Annexins are involved in many
membrane remodeling events that involve actin cytoskeleton
serving as linkers of membrane-cytoskeleton, organization [17].
Annexins are a family of calcium ion dependent phospholipid-
binding proteins. Annexin family is comprised of more than 50
members. Each annexin possesses a short variable N-terminal and
a conserved C-terminal core domain [14,17]. We present evidence
that cochlin-TREK-1 and cochlin-annexin A2 interaction is
commensurate with changes in TM cell shape and motility which




The work was conducted adhering to the guidelines of the
Institute Review board of the University of Miami. All human
samples were handled in keeping with the principles expressed in
the Declaration of Helsinki. All experiments with the human
samples were conducted at the SKB (ocular proteomic laboratory)
lab and the protocol was approved by the Institute Review board
of the University of Miami. A written informed consent was
obtained from all patients undergoing trabeculectomy for primary
open angle glaucoma (POAG) and donating the tissue so obtained
for research. Cadaver human eyes were obtained from National
Disease Research Interchange, Philadelphia with the approval
(exempt under category 4 of NIH guidelines) of the Institute
Review board of the University of Miami. Human TM cell culture
protocol was approved by the Institute Review board of the
University of Miami.
Tissue procurement
Human eyes from normal and POAG donors, all between 40
and 85 years of age (Table S1), were used in this study, and were
obtained from the National Disease Research Interchange. Eyes
were enucleated within 12 h of death and stored at 280uC until
TM tissue was isolated by dissection. Normal control eyes were
from donors with no visual field defects, no evidence of glaucoma,
and without central nervous system abnormalities. Fixed human
TM tissues used for immunohistochemistry were obtained from
the Eye Donor Program of the Foundation Fighting Blindness
(Owings Mills, MD). Glaucomatous eyes and tissues were from
clinically documented POAG donors. Glaucomatous TM tissues
(,1–2 mm
3) were obtained by trabeculectomy from POAG
patients in the BPEI and Mundorf Eye Center (Charlotte, NC)
with institutional review board approval. Human tissue obtained
by trabeculectomy consisted predominantly of TM; however,
possible contamination with small amounts of surrounding tissue
(e.g. sclera) cannot be excluded. TM cells for cell culture were
isolated from the rim tissue associated with corneas used for
transplantation at the BPEI and were obtained from healthy
human eyes within 3 h of death and stored until use in Optisol-GS
medium (Chiron Vision, Claremont, CA).
Western blot analysis
Tissues were dissected out of the enucleated eyes, finely minced,
and proteins were extracted using 50 mM Tris-HCl, pH 7.5,
125 mM NaCl and 0.1% genapol (cat# 345794, EMD Biosci-
ences, La Jolla, CA). Cells were pelleted and subjected to
extraction using the buffer above. The protein extract was
subjected to Western blot analysis. For Western blot the proteins
were separated on 4–20% Tris-glycine gel (cat# EC6028BOX,
Invitrogen, Carlsbad, CA) and then transferred to polyvinylidene
fluoride membranes (PVDF) (cat# 162-0219, BioRad Labratories,
Hercules, CA). For cochlin identification, custom antibodies
against cochlin peptides (KR LKK TPE KKT GNK DC from
cochlin coding region 147–162 designated as hCochlin# 1; ZCZ
TYD QRT EFS FTD YST KEN; from cochlin coding region
412–429 designated as hCochin#2; and CZ DDL KDM ASK
PKE SH from cochlin coding region 358–371 designated as
hCochlin#3, Aves Labs Inc., Tigard, OR) were used [16]. A
secondary antibody conjugated to horseradish peroxidase (goat
anti-chicken cat# H-1004, Aves Labs Inc.) was added and
proteins were detected using enhanced chemiluminescent sub-
strate (cat# 32106, Pierce Thermo Fisher Scientific Inc, Rockford,
IL). GAPDH (anti-GAPDH cat# ab22556, Abcam, Cambridge,
MA) was used as a loading control.
Bioinformatic Analyses
Analyses were carried out for known and predicted protein
interactions for cochlin that include physical (direct) as well as
functional (indirect) associations in different databases (MIPS,
DIP, MINT and String) which encompass and track protein-
protein interaction or co-expression. Additionally, a short list of
proteins encompassing basement membrane, stretch activated
channels and endoplasmic reticulum was prepared for further
investigation. Potential cochlin-interacting proteins or protein co-
expression for cochlin was considered from information derived
from genomic context, high throughput experiments, conserved
co-expression and previous knowledge through data mining these
databases. The shortlist consisted of proteins which appeared in
more than one database. They were initially selected and retained
for further investigation using Western and ELISA analysis if they
were expressed in the trabecular meshwork, ear, kidney and/or
have been shown to be linked to benign intracranial hypertension.
Immunohistochemistry
Human TM sections embedded in paraffin were deparaffinized,
hydrated for 20 m with 16phosphate-Buffered Saline (PBS) (cat#
21-040-CV, Mediatech Inc., Manassas, VA ) and blocked in 16
PBS+0.2% bovine serum albumin (BSA) (Fraction V, cat# 2910,
EMD Chemicals, Gibbstown, NJ) for 30 m. The primary antibody
was added for cochlin and wolframin (WFS1), gasdermin
(GSDMB), diaphonous related formin 1 (DRF1) and alpha-tectorin
(TECTA) in 1:200 dilution [Cochlin: hCochlin #3 (cat# 5007/
5008) Aves Labs Inc., wolframin: cat# sc-47936, Santa Cruz
Biotech, Inc., Santa Cruz,CA. alpha-tectorin: cat#sc-18035,
Santa Cruz Biotech., Inc., gasdermin: cat#sc-79952, Santa Cruz
Biotech., Inc.]. After incubating overnight at 4uC, primary
antibody was washed out with 16 PBS+0.2% BSA 3 times for
10 m per wash., Corresponding secondary antibody was added in
1:1000 dilution (Cy5:, cat#703177155, Jackson ImmunoResearch
Laboratories Inc., West Grove, PA; FITC: cat#IMF-1010, cat#
IRF-1010, Aves Labs Inc.) and incubated for 1 h at room
temperature. The sections were then mounted on glass micro
slides (cat# 48300-0205, VWR International, West Chester, PA)
and stained with DAPI Vectashield (cat# H-1200, Vector
Laboratories). Thus prepared slides were imaged using Leica
DM 6000 B confocal microscope (Leica, Inc.).
Reciprocal immunoprecipitation (IP)
Reciprocal immunoprecipitation for cochlin (hCochlin#3, Aves
Labs Inc.) and annexin (annexin A2: cat# sc-1924, Santa Cruz
Biotech., Inc.) was carried out using established protocols [16].
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alpha-tectorin, diaphanous related formin-1 and
gasdermin in human glaucomatous TM
The TM protein extract was prepared from human normal and
glaucomatous TM as described. The protein extract was subjected
to Western blot analysis. The proteins were separated in 4–20%
Tris-glycine gel and then transferred to PVDF membrane. For
identification of wolframin (WFS1), gasdermin (GSDMB), diapho-
nous related formin-1 (DRF1) and alpha-tectorin (TECTA), the
corresponding primary antibodies were used (wolframin: cat# sc-
47936, Santa Cruz Biotech. Inc.; gasdermin: cat#sc-79952, Santa
Cruz Biotechnology Inc.; DRF1: cat# HPA004916, Sigma-
Aldrich; alpha-tectorin: cat#sc-18035, Santa Cruz Biotech. Inc.)
at recommended dilutions. A secondary antibody conjugated to
horseradish peroxidase (cat# ab6885, Abcam) was added and
proteins were detected using enhanced chemiluminescent sub-
strate (cat# 32106, Pierce Thermo Fisher Scientific Inc.).
TM cell culture experiments
Primary human TM cells were cultured from cadaveric corneo-
scleral sections obtained from the Bascom Palmer Eye Bank
(BPEI) and Mundorf Eye Centre (Charlotte, NC). The cells were
isolated through a blunt dissection of the area containing and
adjacent to the canal of Schlemm, followed by 2 h digestion in 16
PBS (cat# 21-030-CV, Mediatech Inc.) suspension of 20%
0.01 mg/ml collagenase-A (cat# LS004194, Worthington, Lake-
wood NJ). The blunt dissection and the proteolytic treatment were
performed inside a 12 well culture plate (cat# 665-180 Greiner
Bio-One, Neuburg, Germany). Culture media containing DMEM
16(cat# 10-017-CM, Mediatech Inc.), 10% heat inactivated fetal
bovine serum (FBS) (cat# 35-016-CV, Mediatech Inc.), 0.5%
1.7 mM L-Glutamine (cat# G6392, Sigma-Aldrich), 1% Antibi-
otic-Antimycotic solution (cat# 30-004-CL, Mediatech Inc.)] was
added after 2 h to terminate digestion. A sterile microscopy slide
(cat# 56700-194, VMR) was placed on top of the tissue fragment
to ensure bottom contact and immobility inside the media well.
The sections were cultured at 37uC, in a 5% CO2 cell culture
incubator. Cultures were washed with 16 PBS 7 days later to
remove tissue debris; media change occurred every 3–4 days. Thus
obtained cells were trypsin treated (cat# 25-050-Cl, Mediatech
Inc.) and accordingly distributed the day before the transfection
Transfection complexes were created using a ratio of 0.4 mg/mlo f
respective vector DNA to the transfection agent (Lipofectamine
2000, cat# 11668-019, Invitrogen), prepared according to the
manufacturer’s instructions. Following the addition of the
complexes to the selected culture wells, the transfection reactions
were allowed to take place over a 2.5 h span, after which they
were terminated through the addition of cell culture media. Cell
assays and immunohistochemical analysis were performed at or
within 24 h in order to observe and track the effects of vector
expression on morphological changes. Time-lapse microscopy was
performed using cells grown on glass bottom chamber slides (cat#
154534, Lab-Tek, Thermo Fisher Scientific Inc., Rochester, NY)
using the Zeiss AxioVert 200 M microscope (Carl Zeiss Inc) for
the duration of 20 h, with 15 minutes snapshot frequency,
initiated at 24 h post-transfection. Immunohistochemical analysis
was performed on cells grown on glass 18 mm glass cover slides
(cat# 48380-046, VWR), fixed with 4% PFA (USB Corp) at time
intervals of 0, 24, and 29 h post-transfection. Fixed cells were
initially blocked in 16PBS+0.2% BSA for 1 h and incubated with
the respective primary antibodies for cochlin, TREK1, actin,
annexin A2, alpha-tectorin, green fluorescence protein (GFP) and
diaphonous related formin-1 in the dilution factor of 1:200 in 16
PBS+0.2% BSA overnight (Cochlin: hCochlin #3, cat# 5007/
5008; Aves Labs Inc.; TREK-1: cat# ab83932, Abcam; Actin:
secondary probing complexed with phalloidin; annexin A2: cat#
sc-1924, Santa Cruz Biotech. Inc.; alpha-tectorin: cat# sc-18035,
Santa Cruz Biotech. Inc., GFP: cat# 600-301-215, Rockland Inc.,
diaphonous related formin-1: cat# HPA004916, Sigma-Aldrich).
Subsequently, the coverslips were washed three times in 16
PBS+0.2%BSA for 10 m, and incubated with corresponding
secondary antibodies for 1 h diluted 1:1000 in 16PBS+0.2% BSA
(FITC: cat# IMF-1010, Aves Labs Inc.; Rhodamine/Phalloidin:
cat# R415, Invitrogen; A546: cat# A10040, A11056, Invitrogen;
A594: cat# A11042, Invitrogen; A647:cat# A21449, A21446,
A31573, Invitrogen, Cy5: cat# 711-176-152, Jackson ImmunoR-
esearch Labs. Inc.), mounted on glass slides (cat# 48300-025,
VWR), stained with DAPI Vectashield (Vector Labs), and finally,
imaged using confocal microscopy (Leica DM6000 B) at
magnification of 406/636with oil immersion. Media for excreted
protein analysis was collected at 24 h post transfection and
subjected to ELISA probing for cochlin (hCochlin#3, Aves Labs
Inc.) and annexin A2 (Santa Cruz Biotechnology Inc).
HEK-293T [cat# 293T/17 (CRL-11268), ATCC, Manassas,
VA] and COS-7 [cat# COS-7 (CRL-1651), ATCC] cells were
transfected with plasmid expressing cochlin (GeneCopoeia) or
annexin A2 [18]. Twenty-four hours post-transfection, media was
collected and subjected to Western blot analysis probing for
cochlin and annexin A2 with their corresponding primary
antibodies (hCochlin#3, Aves Labs Inc, annexin A2: Abcam).
The cells were trypsin treated (Mediatech Inc.) and centrifuged at
1,000 rpm for 5 m. The supernatant was discarded and protein
extraction buffer (as described for TM protein extraction) was
added. The cells were centrifuged again at 10,000 rpm for
10 minutes. The supernatant obtained was then preserved and
used for Western blot analysis.
Methylcellulose gel cochlin release experiment
For a direct, aseptic and localized delivery of gel suspension, a
hole was bored through the side of a 35 mm glass bottom culture
dish (cat# P35G-1.0-20-C Mat-Tek Corp., Ashland MA), through
which a borosilicate capillary (cat# TW100-6, WPI Inc, Sarasota
FL) was inserted. The capillary was secured at an angle from the
outside using moldable adhesive (cat# 08-0102, Crayola, Shelton,
CT) with its outlet fixed to one particular area at the bottom of the
culture plate. Prior to plating the cells, the above described setup
was UV sterilized and washed several times with 16PBS to ensure
sterile conditions.
TM cells were introduced and allowed to be 50% confluent.
Subsequently, the setup was placed inside microscope culture
chambers (Zeiss Axiovision 200 M, Carl Zeiss Inc.), maintaining
continuous temperature at 37uC and CO2 concentration at 5%. A
suspension containing 1% methylcellulose suspended in H2O
(cat# 274445, Sigma-Aldrich) and 10% by volume purified
cochlin was prepared and drawn into a 1 ml syringe (cat# 13675-
09, Henke-Sass-Wolf, Tuttlingen, Germany) . This suspension was
then injected into the external end of the borosilicate capillary and
allowed to reach the opposite end. Time-lapse microscopy was
initiated with specific aim to focus at the immediate area around
the output capillary end and the surrounding cells. The time-lapse
was initiated immediately following the introduction of the
methylcellulose-cochlin time-released suspension and continued
for 20 h (images were captured every 15 minutes).
Voltage sensitive dye experiment
Human TM cells were cultured as described above in 35 mm
glass bottom dishes (Mat-Tek Corp.). At 90% confluence, the cells
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Thirty six hours post-transfection the cell culture media was
replaced with 16 PBS at 37uC (cat#14040, Invitrogen) and the
culture was imaged in real time using Leica DMI 16000 CS
Inverted Scanning confocal microscope (Leica Inc.) at a fixed 493–
596 nm spectral emission-excitation wavelength field, specific to
the dye molecule being studied. Following the initial snapshot of
selected number of cells, bis-(1, 3-dibutylbarbituric acid) tri-
methine oxonol [DiBAC4(3) or DiBAC] (cat# B-438, Invitrogen)
was added to the 16PBS bathing the cells to a final concentration
of 1 mM in the solution. Secondary live snapshot was taken
10 minutes following the addition of DiBAC. The fluorescence
intensity was quantified for 100 randomly selected cells before and
after DiBAC addition using Leica LAS software (v. 2.3.0, build
5131, Leica Inc.)
Cochlin and annexin A2 secretion pathway
TM cells were transfected with COCH gene carrying vector
(GeneCopoeia Inc.). They were incubated in the presence or
absence of caspase-1 inhibitor (10 nM) (cat# 60856, AnaSpec,
Fremont, CA) or pan-caspase inhibitor (10 nM) (cat# 60861,
AnaSpec, Fremont, CA) or Golgi disruptor, brefeldin (5 mg/ml)
(cat# 203729-1MG, EMD Chemicals). The concentrations used
did not produce cytotoxicity as assessed by trypan blue exclusion.
The media was collected 24 h post transfection and subjected to
ELISA analysis probing for cochlin and annexin A2.
Overlay assay
Human TM was used to prepare protein extract as described.
TM cells were cultured and transfected with HA-tagged cochlin.
24 h post-transfection the media was collected. 100 mg of protein
extract and media (from transfected cells) were subjected to non-
reducing 10% SDS-PAGE (Invitrogen). The proteins were
transferred onto a PVDF membrane which was washed five times
with IX TBS to remove SDS and then soaked in the media
containing the recombinant HA-tagged cochlin. The membrane
was washed and subjected to probing with antibody against HA
(cat# sc-805, Cruz Biotechnology Inc.), stripped and further re-
probed with antibody against cochlin (hCochlin#3 antibody, Aves
Labs Inc.).
Oleylamine experiment
Primary TM cells were cultured as described earlier in a 12 well
plate (Greiner Bio-One) on top of glass cover-slide (VMR). The
cells were transfected with a plasmid containing the GFP tagged
cochlin vector (GeneCopoeia, Inc.) as described in the TM cell
culture methods. Oleylamine (cat# O7805, Sigma-Aldrich), a
known inhibitor of TREK-1 potassium channel function (but not
mechanotransduction function) [12] was added to one set of
cochlin transfected cells to achieve a final concentration of 5 mM.
Another set of cochlin-transfected cells was used as the control.
Cells grown in the presence or absence of oleylamine were fixed
with 4% paraformaldehyde (USB Corp) after 24 h. The glass
cover-slides thus obtained were used for immunohistochemical
analysis using confocal microscopy and the methods as described
previously.
Results and Discussion
Mechanotransduction may induce alterations in cell shape and
motility within the TM. Cultured primary human TM cells were
used to demonstrate the effects of cochlin, TREK-1 and annexin
A2 on cellular morphology. Control untransfected TM cells show
straight smooth edges. In contrast, cochlin, annexin A2 and their
co-transfection result in sharp, thin and elongated filopodia,
stretched cells with multiple hair-like projections and thicker
spread out filopodia like structures (Figure 1A). These data suggest
that cell shape changes concomitant with cochlin or annexin A2
overexpression. Secreted cochlin from transfected cells modulates
the morphology of adjacent untransfected cells (Figure 1B and
Movie S1). Cochlin secreting cells show a transparent leading edge
(round filopodia), while untransfected cells show filopodia moving
away from regions of high cochlin concentration (Movie S1). We
next used time-lapse microscopy, exogenous purified recombinant
cochlin and TM cells to demonstrate how cochlin concentration
gradients promote filopodia formation. Exogenous cochlin laden
methylcellulose gel pellets were placed adjacent to TM cells
(Figure 1C and Movie S2). TM cells developed elongated filopodia
in response to released exogenous cochlin and retracted away from
the cochlin gradient (Figure 1C and Movie S2), similar to what
was observed for TM cells adjacent to cochlin transfected cells
(Figure 1B and Movie S1).
TM cells demonstrated co-localization of cochlin and TREK-1
at the initial stages of cochlin expression at approximately
23.5 hours post-transfection at the leading edges of the protrusions
(Figure 2A). At 24.5 and 29 hours post-transfection, increased
expression of TREK-1 was observed at the leading edges of
filopodia-like growths. TREK-1 and cochlin expression occurred
extensively throughout the cell with increased expression at the
leading edges at later stages of cell growth.
Cochlin transfected cells also show localization of cochlin and
annexin A2 (Figure 2B and Figure S1A). At early stages of cochlin
expression (,24 hours), annexin A2 localized close to the nucleus;
the protein expression shifted toward filopodia at later (29 hours)
stages (Figure 2B). These results suggest that cochlin and TREK-1
follow similar expression kinetics with respect to initial filopodia
formation. Annexin A2 follows the course of cochlin expression
and likely plays a role in filopodia extension and enlargement. The
co-expression of cochlin and TREK-1 is consistent with their role
in mechanosensing and mechanotransduction.
We next probed functional interaction between cochlin and
TREK-1 using the voltage sensitive dye, bis-(1, 3-dibutylbarbituric
acid) trimethine oxonol (DiBAC). Activation of TREK-1, an
inward rectifying K
+ channel [19] prevents inward DiBAC
transport resulting in lower fluorescence. TM cells transfected
with TREK-1+cochlin showed lower fluorescence intensity
compared to control TREK-1+ Retinoid isomerohydrolase
(RPE65) transfected cells incubated in presence of DiBAC
(Figure 2C and Figure S2A). Retinoid isomerohydrolase, an
ocular protein with a molecular size similar to cochlin was chosen
as a control. TM cells transfected with cochlin and cultured in the
presence or absence of 5 mm oleylamine, a cationic lipid inhibitor
of TREK-1 channel activity [12], showed an unchanged ratio of
cells developing filopodia compared to the total number of cells
(Figure 2D, E and Figure S2B) suggesting TREK-1 mediated
morphological changes in TM cells (Figure 2A) are independent of
the channel activity. These findings are consistent with a prior
report [12] in other cell types.
Overall, changes in cell shape and motility should create open
spaces for fluid outflow. We reasoned that such expansion of the
TM slit-like filter should be reflected in cochlin overexpressing TM
cells on a matrix. The contribution of cochlin and TREK-1 to
space expansion for fluid flow probed using collagen gel assays
[20] suggest gel expansion requires the presence of both TREK-1
and cochlin (data not shown).
Mechanotransduction in osteocytes and other systems [21,22],
suggests dynamic interplay between secreted and basement
membrane proteins for cellular remodeling. Significant modula-
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expression of select basement membrane and endoplasmic
reticulum proteins. Extensive bioinformatic analyses for known
and predicted protein interactions for cochlin in various databases
enabled us to short-list select proteins for further investigation,
namely: diaphanous related formin-1 (DRF1), alpha-tectorin
(TECTA), gasdermin (GSDMB) and wolframin (WFS1), which
were found to be elevated in human glaucomatous TM
(Figure 3A). Diaphanous related formin-1 is usually present in
the tip of the membrane ruffles in motile cells, nucleates actins and
acts in a Rho-dependent manner. It is required for the assembly of
F-actin structures, such as actin cables and stress fibers [23]. Rho-
mediated actin rearrangement has been noted in TM cells which
have been implicated in regulation of aqueous outflow [13].
Diaphanous related formin-1 is known to regulate actin polymer-
ization in hair cells [23]. Gasdermin, a cytosolic protein have been
implicated in playing a role in general in cellular protein secretion,
hence it may play a role for secretion of cochlin and annexin. The
expression of gasdermin is associated with cell motility as well [24].
Alpha-tectorin is one of the major non-collagenous components of
the tectorial membrane. The tectorial-membrane is an extracel-
lular matrix of the inner ear. Alpha-tectorin is implicated in
transduction of sound signals in the inner ear. All tectorins are
likely synthesized as glycosylphosphatidylinositol-linked, mem-
brane-bound precursors and proteolytically released into the
extracellular compartment. Gene expression omnibus database
search shows presence of alpha-tectorin at mRNA level in the TM
(accession number GDS 359).Like annexin A2, alpha-tectorin is
anchored to the membrane with a lipid anchor and released into
ECM under certain conditions[25]. Wolframin (WFS1) is a
transmembrane protein of the endoplasmic reticulum (ER) that
participates in the regulation of cellular calcium ion homeostasis.
Elevated levels of wolframin can cause ER stress and elevated
intracellular calcium. Defects in WFS1 are the cause of Wolfram
syndrome (WFS) also known as diabetes insipidus and mellitus
with optic atrophy and deafness syndrome [26,27]. Analyses
Figure 1. TM cells exposed to high cochlin concentration develop filopodia. (A) Representative images of primary TM cells. The TM cells
were either left untransfected or were transfected with plasmids expressing cochlin or annexin A2 or both cochlin and annexin A2 as indicated. Nuclei
were stained with DAPI (blue). Actin is stained in red and green fluorescence shows GFP expression. Inset shows graphic representation of
representative TM cell morphology for the transfection types as described. Scale bar, 10 mm (1st column), 25 mm (2nd and 3rd columns), 50 mm (4th
column). (B) Morphological changes in a TM cell exposed to cochlin secreted from an adjacent cell transfected with the plasmid expressing cochlin
and green fluorescence protein (GFP). Scale bar, 50 mm. (C) Morphological changes in a TM cell exposed to a steady sustained release of cochlin from
a methylcellulose gel pellet (arrows and semicircle) impregnated with purified recombinant cochlin. Arrows track the course of cochlin vesicles from
methylcellulose gel to the TM cells. Scale bar, 100 mm.
doi:10.1371/journal.pone.0023070.g001
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tectorin, actin and co-localization of cochlin, annexin A2 and
TREK-1 in normal primary TM cells (Figure 3B) and in tissues
(Figures 3C–F).
Annexin A2 is a multifunctional protein, associated with
morphological changes and elongation in a variety of cell types.
If cochlin induces alteration in cell shape and motility, expression
of proteins associated with cell elongation, for example, annexin
A2 would be anticipated to increase, concomitant with elevated
cochlin secretion. Normal TM cells have low secreted cochlin and
annexin A2 levels. However, TM cells transfected with COCH
secrete cochlin, as well as annexin A2. In contrast TM cells
transfected with annexin A2 plasmid do not secrete any more
annexin A2 than untransfected cells (Figure 4A). HEK-293T and
Figure 2. Overexpression of cochlin causes morphological changes in TM cells and cochlin and TREK-1 interaction has functional
implications. (A) Immunocytochemical analysis of cells expressing cochlin and green fluorescence protein (GFP). The cells were imaged at 23.5, 24.5
and 29 hours post-transfection as indicated and probed for TREK-1 (red), GFP (green) and cochlin (pink). Arrows show localization of cochlin and
TREK-1 in the filopodia. Scale bar, 5 mm (top panel), 50 mm (middle panel), 25 mm (bottom panel). (B) Immunocytochemical analysis of cells
expressing cochlin and GFP. The cells were imaged at 24 and 29 hours post-transfection as indicated and probed for annexin A2 (red) and cochlin
(pink). Scale bar, 25 mm. (C) Comparison of relative fluorescein intensity in the TM cells transfected with TREK-1+ RPE65 and TREK-1+COCH before and
after the addition of DiBAC as indicated. Results from five different experiments are shown (mean 6 SD). (D) Comparison of filopodia induction in the
cells cultured in the presence or absence of oleylamine (5 mM). Results from three different experiments are shown (mean 6 SD). (E) Representative
images of cells expressing cochlin and GFP when grown in the presence or absence of oleylamine (5 mM) as indicated. Scale bar, 50 mm. In all sections
nuclei were stained with DAPI.
doi:10.1371/journal.pone.0023070.g002
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transfected with cochlin constructs, these cells secrete both
cochlin and annexin A2 into the media. Recombinant annexin
A2 expression in these cells results in elevated annexin A2 in cell
lysates but not its secretion (Figures 4B and 4C). Thus, the
transfection of cochlin results in secretion of annexin A2, yet
annexin A2 overexpression by itself does not lead to its secretion.
Previous mass spectrometric analysis indicated the interaction of
cochlin with annexin A2 [16]. Cochlin-annexin A2 interactions
were demonstrated by reciprocal IP (Figure 4D). In addition to
reciprocal IP, we also performed overlay assay which is an
independent method to demonstrate protein-protein or protein-
lipid interactions [28,29]. Briefly, the proteins in a tissue or cell
lysate, fractionated by electrophoresis and transferred on a
membrane are subjected to interaction with target protein
which is subsequently immunodetected. Overlay assays further
Figure 3. Concomitant elevated levels of select basement membrane and ER proteins with cochlin overexpression. (A) Western
analysis of normal (N) and glaucomatous (G) human TM protein extract were probed with anti-diaphanous-related formin-1, anti-alpha-tectorin, anti-
gasdermin, anti-wolframin and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibodies as indicated. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) is shown as a loading control. Diaphanous-related formin-1 , alpha-tectorin, gasdermin-B and wolframin are expressed in
human TM. (B) Immunocytochemical analysis of primary TM cells showing the level of expression of cochlin, TREK-1, annexin A2, actin, alpha-tectorin
and diaphanous-related formin-1. Scale bar, 25 mm (C–F) Immunohistochemical analysis of human TM sections showing the presence of diaphanous-
related formin-1, alpha-tectorin, gasdermin-B and wolframin as indicated. Sections were also stained with DAPI to outline the anatomy. Scale bar,
50 mm.
doi:10.1371/journal.pone.0023070.g003
Cochlin, TREK-1 and Annexin A2 in Cell Physiology
PLoS ONE | www.plosone.org 7 August 2011 | Volume 6 | Issue 8 | e23070corroborated cochlin-annexin A2 interaction (Figure 4E). These
results suggest basement membrane proteins are elevated
concomitant with secretion of cochlin in glaucomatous tissue
and interaction of cochlin with TREK-1, stretch-activated
channel (SAC) proteins and annexin A2 may mediate effects of
cochlin.
Using caspase inhibitors as tools for probing non-classical
protein secretion [30], we further determined that cochlin is
Figure 4. Concomitant expression and secretion of annexin A2 with cochlin overexpression. (A) ELISA analysis of the media collected
from TM cells transfected with cochlin or annexin A2 or untransfected shows some basal secretion of cochlin and annexin A2 by the TM cells which is
greatly augmented by cochlin overexpression but not by annexin A2 overexpression (mean 6 SD). (B–C) Western blot analysis of the media and cell
lysates, collected from HEK-293T cells transfected with cochlin or annexin A2 as indicated. Purified cochlin and annexin A2 are shown as positive
controls. (D) Reciprocal IP of cochlin and annexin A2 from human TM extract, probed with antibody against either cochlin or annexin A2 as indicated,
anti-citrulline IP served as control. IP=Immunoprecipitation; WB=Western blot (E) Overlay assay of human TM extract and media from HA-tagged
cochlin transfected cells shows both cochlin and annexin A2 when probed with antibodies against HA or subsequently against cochlin as indicated.
Cochlin interacts with annexin A2 and augments secretion of the latter by the non-classical pathway. (F) ELISA analysis of the media collected from
primary TM cells transfected with cochlin shows increased secretion of cochlin and annexin A2 by cochlin transfected cells as compared to mock
transfection. Golgi disruptor Brefeldin has a greater effect on cochlin secretion, and caspase-1 inhibitor and pan-caspase inhibitor have greater effect
on annexin secretion.
doi:10.1371/journal.pone.0023070.g004
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annexin A2 secretion is likely mediated by the non-classical
pathway (Figure 4F). Annexin A2 secretion (but not cochlin) was
significantly reduced in HEK-293T cells when incubated with
caspase-1 or pan-caspase inhibitor but not with brefeldin
(Figure 4F). Brefeldin is an inhibitor of classical protein secretion
which inhibits transport of proteins from endoplasmic reticulum
[31]. These results suggest that secretion (annexin A2) or levels
(diaphanous related formin-1, alpha-tectorin) of select proteins
that contribute to cytoskeletal remodeling are modulated by
cochlin. Diaphanous related formin-1 expression was found at the
leading edges of filopodia, consistent with actin reorganization
(Figure S1B) in cochlin transfected TM cells. Similarly diaphanous
related formin-1 and alpha-tectorin were also found in the leading
edges of TM cells transfected with cochlin (Figures S1C and S1D).
These results suggest association of annexin A2 and diaphanous
related formin-1 with cell elongation.
Both mono- and multimeric cochlin have been found to interact
with SACs such as TREK-1, TASK-1 and choline transporter-like
protein 2 (SLC44A2). Multimeric cochlin is proteolysis resistant
and reside for longer periods in the TM (data not shown). TM cells
function in an environment of continuous varying mechanical and
fluid shear forces [32]. Our understanding of molecular mechan-
osensors and their role in transduction of stimuli into cellular
biochemical signals that ultimately regulate cellular function [33]
is very limited. Reversible multimerization of cochlin caused by
shear stress can act as potential mechanosensing mechanisms. The
data presented here suggests that mechanical forces are possibly
transmitted through cochlin-TREK-1 protein-protein interactions.
Our findings link ECM mechanosensing by cochlin with
transmembrane mechanotransduction mediated by TREK-1
resulting in modulation of cytoskeletal proteins [34,35].
The modulation of cell shape and motility and overall space
expansion mediated by cochlin should induce overall TM filter
changes and result in increased fluid flow. Taken together, these
data suggest interaction of cochlin with TREK-1 is involved in
formation of filopodia-like protrusions. These processes are likely
to contribute to expansion of cells in the gel, consistent with
opening spaces between cells and increased transport of sodium
fluorescein across cell layer matrix, suggesting a regulatory role
for cochlin and TREK-1 in fluid flow across TM tissue. Indeed
TM cells overexpressing cochlin but not a control protein
Retinoid isomerohydrolase of identical size has been found to
contribute to gel expansion and to augment transport of
fluorescein across cell layer (data not shown). Our results suggest
mechanotransduction by cochlin and TREK-1 of fluid flowing
through the ECM can modulate the expression of several
cytosolic proteins, for example, diaphanous related formin-1,
alpha-tectorin and Profilin I and induce actin cytoskeletal
remodeling [36] concomitant with increased outflow facility
[37], and reduction of IOP [38,39].
Our observation of cochlin-TREK-1 co-expression (Figure 2A)
is consistent with their initiation of changes in the space between
cells within TM filter. The kinetics of annexin A2 appearance is
consistent with cytoskeletal remodeling (Figure 2B) and late
cellular changes associated with TM remodeling and expansion
resulting in enhanced fluid flow across cell layers (data not shown).
Maximum resistance to aqueous outflow is localized to the
juxtacanalicular tissue of the TM [40]. Studies suggest TM cells
dynamically regulate outflow facility by rearranging their cyto-
skeleton, thus enhancing aqueous outflow [41]. Our results
provide insight into the physiology of TM outflow regulation
and suggest a role for fluid shear mechanosensing in the aqueous
humor outflow process.
Supporting Information
Figure S1 Cochlin overexpression alters the morpholo-
gy of TM cells. (A) Representative confocal microscopy images
of TM cells transfected with a plasmid bearing the GFP tagged
COCH vector. Images were obtained 24 hours post-transfection
and show co-localization of cochlin (pink) and annexin A2 (red) in
the filopodia. Scale bar, 25 mm (Top panel), 50 mm (Bottom panel)
(B) Representative confocal microscopy images of TM cells
transfected with a plasmid bearing the GFP tagged cochlin vector.
Images were obtained 24 hours post-transfection and show co-
localization of cochlin (pink) and actin (red) in the filopodia. Scale
bar, 25 mm (C) Representative confocal microscopy images of TM
cells transfected with a plasmid bearing the GFP tagged cochlin
vector. Images were obtained 24 hours post-transfection and show
co-localization of cochlin (pink) and diaphanous related formin-1
(red) in the filopodia. Scale bar, 25 mm (D) Representative
confocal microscopy images of TM cells transfected with a plasmid
bearing the GFP tagged cochlin vector. Images were obtained
24 hours post-transfection and show co-localization of cochlin
(pink) and alpha-tectorin (red) in the filopodia. Scale bar, 25 mm.
(EPS)
Figure S2 TREK1 and cochlin interaction alter the
membrane potential but the morphogenic effect is
independent of channel activity. (A) Comparison of relative
fluorescein intensity in the TM cells transfected with TREK-
1+RPE65 (top panel) and TREK-1+COCH (bottom panel) before
(left side) and after (right side) the addition of bis-(1, 3-
dibutylbarbituric acid) trimethine oxonol (DiBAC). Each colored
line represents the data obtained from one cell. The fluorescein
intensity is shown on the x-axis and the number of pixels showing
that particular intensity is shown on the y-axis. (B) Representative
confocal microscopy images of TM cells transfected with the
plasmid expressing cochlin tagged with GFP grown in the presence
(top panel) or absence (bottom panel) of 5 mM oleylamine. Scale
bar, 50 mm.
(EPS)
Table S1 Information of tissue donors. A categorical and
relevant medical details of donors have been provided.
(XLS)
Movie S1 Exposure to cochlin causes morphological
changes in TM cells. A cochlin transfected TM cell, seen in this
video as having a round transparent leading edge and displaying
the GFP, releases cochlin into the surrounding media. This high
concentration of cochlin in the media causes the cell adjacent to it
to develop filopodia in response and move away from the
concentration gradient.
(ASF)
Movie S2 Exogenous cochlin causes TM cells to move
away from the concentration gradient. Cochlin is secreted
into the media by the methylcellulose gel loaded with cochlin. As
the cochlin containing vesicles reach the TM cells, they bring
about a change in the morphological features of the cells. The
video here shows how under the influence of cochlin two adjacent
TM cells develop filopodia and retract away from each and thus
increase the intercellular space.
(ASF)
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